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Abstract The synthesis of the natural product 3-epi-casuarine and two tricyclic ether bridged 
analogues, plus 7-deoxy-3,6-diepi-casuarine, 7-epi-australine, 1-epi-castanospermine and 1,6-
diepi-castanospermine is described. The glycosidase inhibitory activities of these compounds, 
along with that of uniflorine A and other polyhydroxylated pyrrolizidines and indolizidines that 
we have published before, are reported.  
 
1. Introduction 
The polyhydroxylated 3-hydroxymethylpyrrolizidine group of natural products includes, 
uniflorine A 1,1,2,3 casuarine 2,4 australine 3,5 3-epi-australine 46,7 (Figure 1), alexine8 (7a-epi-
australine), several other epi-australines (1-epi-australine, 3-epi-australine, 2,3-diepi-australine, 
2,3,7-tri-epi-australine),9 1-epi-australine-2-O--glucoside, 3-epi-casuarine,10 and casuarine-6-O-
-glucoside.11 The hyacinthacine alkaloids are a more recent addition to this group of which 
nineteen novel compounds have been identified.12 This group, along with the polyhydroxylated 
pyrrolidine, piperidine, indolizidine and nortropane alkaloids, have glycosidase inhibitory 
activities and thus have potential utility as antiviral, anticancer, antidiabetic and antiobesity 
drugs.7 Three structurally related synthetic compounds have been marketed as antidiabetic drugs 
to treat type-2 diabetes based on their potent -glucosidase inhibitory activities while others 
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have been identified as candidates for therapeutics to treat type-1 Gaucher disease.7 These 
potentially useful biological activities along with the stereochemical richness of these alkaloids 
have made these compounds attractive and important synthetic targets.13  
We recently reported the synthesis of uniflorine A 1 from the chiral 2-substituted-2,5-
dihydropyrrole 5 (Scheme 1) which is readily prepared in four synthetic steps from L-xylose.13 
We also demonstrated that compound 5 is a versatile precursor for the diastereoselective 
synthesis of the alkaloids casuarine 2, australine 3 and 3-epi-australine 4 and the unnatural 























































In this paper we describe our attempts to prepare the natural product 3-epi-casuarine 710 from the 
epoxide 6 that we have synthesized previously in seven steps from 5.13 This synthesis also 
resulted in the formation of two tricyclic bridged ether analogues of 3-epi-casuarine. The 
synthesis of 7-deoxy-3,6-diepi-casuarine, 7-epi-australine, 1-epi-castanospermine and 1,6-diepi-
castanospermine is also described. The glycosidase inhibitory activities of these compounds, 
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along with that of uniflorine A 1 and other polyhydroxylated pyrrolizidine and indolizidines that 
we have published before, are reported. 
 
2. Results and Discussion 
Our anticipated synthesis of 3-epi-casuarine 7 from the epoxide 6 (Scheme 2) involved a 
regioselective ring-opening reaction of the epoxide moiety of 6 with NaHSO4,
14 a reagent that 
we had successfully applied to the synthesis of casuarine 2 from 3-epi-6.13 
Scheme 2  
 
The epoxy-pyrrolizidine 6 was treated with NaHSO4/CH2Cl2 under the conditions that we 
described before13 except that heating at 50 °C was continued for 7 d (Scheme 3). We attribute 
the slower rate of epoxide ring-opening of 6, when compared to that of 3-epi- 6, to the increased 
steric hindrance of the -face of the epoxide moiety due to the 3--CH2OTBS substituent. 
Because of the slow reaction rate hydrolytic cleavage of the OTBS group also occurred resulting 
in a mixture of products that was difficult to separate. Acetylation of this mixture and then 
separation by column chromatography gave the desired acetylated product 8 (7% yield), the 
epoxide 9 in 9% yield and the undesired tricyclic bridged ether products 10 (8%) and 11 (17%) 
(Scheme 3). The isolation of epoxide 9 indicated that OTBS cleavage was faster than either the 
4 
 
intermolecular or intramolecular (leading to tricyclic bridged ether products) epoxide ring-
opening reactions. Unfortunately, several attempts to improve the yield of the desired compound 
8 were not successful. While the use of a more stable protecting group for the primary alcohol 














































































aReagents and conditions: (a) i: NaHSO4, CH2Cl2, 50 
oC, 7 d; ii: Ac2O, py, DMAP, 24 h; (b) PdCl2, 
H2 (1 atm), MeOH, 4 d; ion-exchange, 77%; (c) Amberlyst OH, MeOH, rt, 12 h; PdCl2, H2 (1 
atm), MeOH, 24 h; ion-exchange, 82%; (d) Amberlyst (OH─), MeOH, rt, 16 h; PdCl2, H2 (1 
atm), MeOH, 12 h; ion-exchange, 53%. 
 
Hydrogenolysis of 8 over PdCl2/H2 in MeOH for 4 d gave diastereomerically pure 3-epi-
casuarine 7 ([] 25D +2.0 (c 0.4, H2O), lit.
10 [] 23D +5.7 (c 0.5, H2O)) in 77% yield after purification 
by ion-exchange chromatography (Scheme 3). The 1H NMR spectroscopic data (D2O) of 7 and 
those of the natural product  were essentially identical (ΔH = 0.01─0.02 ppm) as were the 13C 
NMR chemical shifts (ΔC = 0.0─0.1 ppm).10 The reasons for the difference in the magnitude of 
the optical rotation between our synthetic 7 and the natural isolate were perhaps due to the 
relatively small amount of sample we had, compared to that obtained from the natural source, 
which may have lead to difficulties in drying (slightly hydroscopic) and weighing our sample. 
The relative ratio of 10 and 11 (ca 1:2) was consistent with their relative heats of 
formation as calculated using PC Spartan (AM1). The calculated heat of formation of 10 
(─122.3 kcal/mol) was more than that of 11 (─129.8 kcal/mol) suggesting 10 had more ring 
strain than 11. This energy difference would be expected to be reflected in the differences in 
transition state energies leading to these regioisomeric products. The identities of 10 and 11 were 
established by 1D and 2D NMR analysis. The 1H NMR spectrum of 10 showed that the most 
downfield proton (H-6) at 5.24 (dd, 1H, J = 6.4, 2.8 Hz) ppm was coupled to two of the 
diastereotopic H-5 protons at 3.65 (dd, 1H, J = 14.4, 6.4 Hz, H-5) and 2.85 (dd, 1H, J = 14.4, 
2.8 Hz, H-5) ppm. The H-5 and H-5 protons were individually assigned based upon their 
vicinal coupling constants to H-6 and from NOESY NMR spectra. Using PC Spartan (AM1) the 
dihedral angle () between H-6 and H-5 was 120.3° and between H-6 and H-5 was 0.2°. 
Based on the Karplus equation15 J5,6 should be 3─6 Hz and J5,6 8.5─12.5 Hz. The larger 
observed vicinal coupling constant (6.4 Hz) between H-6 and the two H-5 protons was therefore 




NMR spectrum of 11 (H-7) resonated at 4.97 (brs, W1/2 = 1 Hz, 1H) ppm and showed a weak 
COSY cross peak to H-5 (W-coupling). The calculated dihedral angle from PC Spartan (AM1) 
between H-7 and H-6 was 99.2° and between H-7 and H-7a was 128.8°. From the Karplus 
equation J6,7 should be 0─3 Hz and J7,7a 3─7 Hz. The coupling constants observed for H-7 were 
consistent with the calculated J values and the structure of 11. The structures and relative 

















Figure 1 Structures of 10 and 11 from PC Spartan (AM1).  
 
The NOESY correlation between H-7a and H-5 in 10 indicated that these protons were on the 
same face of the ring. The correlation between H-5 and H-8 indicated that H-3 was on the 
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opposite face to H-5. The NOESY correlation between H-3 and H-2 indicated that they were on 
the same face of the ring. Furthermore NOESY correlations between H-6 and H-8 further 
supported the structure of 10 as shown in Figure 1. NOESY experiments on 11 showed 
correlations between H-7 and H-1, H-7a and H-5 and H-2 and H-3. H-5 showed a weak 
correlation to H-8. These correlations further supported the structure assigned to 11. 
 The acetate group of 10 was first removed using amberlyst (OH─ form) in MeOH and 
then hydrogenolysis over PdCl2/H2 in MeOH for 1 d gave the deprotected tricyclic bridged ether 
derivative 12 [] 23D +8.6 (c 0.5, MeOH), in 82% yield after ion-exchange chromatography 
(Scheme 3). Following the same two step deprotection method described above, compound 11 
was converted to the tricyclic derivative 13 [] 23D +7.6 (c 0.34, MeOH), in 53% yield after 
purification by ion-exchange chromatography (Scheme 3).  
In order to prepare further polyhydroxylated pyrrolizidine and indolizidine derivatives for 
testing as glycosidase inhibitors several compounds that we obtained as byproducts from our 
earlier studies13 were deprotected and/or modified as indicated in the following discussion. The 
alcohol 14,13 which we had obtained as a minor regioisomeric product from the reductive ring-
opening reaction of 6 with LiAlH4, underwent hydrogenolysis over PdCl2/H2 to provide a 
product that was difficult to purify. This material was subsequently acetylated by treatment with 
Ac2O in pyridine and the peracetylated product was readily purified. Following deacetylation 
using Amberlyst A-26 (OH─) in MeOH then pure 7-deoxy-3,6-diepi-casuarine 15 ([] 23D +28.6 (c 





aReagents and conditions: (a) PdCl2, H2 (1 atm), MeOH, rt, 3 h; then conc. HCl 5 drops; (b) Ac2O, py, 
DMAP, rt, 24 h; (c): Amberlyst A-26 (OH─), MeOH, 3 h, 50% (3 steps). 
 
The previously prepared indolizidine 1613 was treated with LiAlH4 in THF at rt for 20 h 
to provide the indolizidine 17 as the only regioisomeric product in 60% yield. Hydrogenolysis of 
17 under acidic conditions with PdCl2/H2 afforded 1,6-diepi-castanospermine 18 [] 25D ─74.2 (c 
1.5, MeOH), lit.16 [] 24D ─72.0 (c 0.7, MeOH) in 95% yield and 95% purity (Scheme 5). The 
1H 
NMR spectroscopic data (D2O) of 18 were consistently downfield (ΔH = 0.11─0.15 ppm) from 
those reported for the synthetic material prepared by Fleet et al.16  The 13C NMR spectroscopic 
data (in D2O with MeCN as an internal reference at  1.47) of 18 and that reported in the 





aReagents and conditions: (a) LiAlH4, THF, rt, 20 h, 60% (b) PdCl2, H2 (1 atm), MeOH, rt, 4 d; ion-
exchange, 95%. 
 
Hydrogenolysis of a mixture of 19 and 20 (dr 92:8)13 over PdCl2/H2
 followed by 
purification and neutralized by ion-exchange chromatography gave 7-epi-australine 21 in 90% 




17 [] 25D ─13.04 (c 0.55, H2O, pH 8.37)). The 
1H NMR spectroscopic data (D2O) of 21 
were all consistently downfield (ΔH = 0.16─0.18 ppm) of those of the synthetic compound 
prepared by Denmark et al.17. The 13C NMR signals of 21 (in D2O with MeCN as an internal 


























aReagents and conditions: (a) PdCl2, H2 (1 atm), MeOH, rt, 3 h, then conc. HCl rt, 17 h, ion-exchange, 
90%.  
Hydrogenolysis of 2213 over PdCl2/H2
 gave diastereomerically pure 1-epi-
castanospermine 23 ([] 22D +3.3 (c 0.3, MeOH), lit.
18 [] 26D +3.8 (c 0.5, MeOH), in 94% yield after 
ion-exchange chromatography (Scheme 7). The 1H NMR spectroscopic data (D2O) of 23 and 
those of the synthetic compound from Murphy19 were essentially identical (ΔH = 0.02─0.03 
ppm). The 13C NMR signals of 23 (in D2O with MeCN as an internal reference at 1.47 ppm) 
however, were all consistently 1.7─1.8 ppm downfield of those reported previously. However 







aReagents and conditions: (a) PdCl2, H2 (1 atm), MeOH, rt, 3 h, then conc. HCl rt, 21 h, ion-exchange, 
94%. 
 
 A comparative study of the inhibitory activities of alexine, australine, casuarine and some 
of their epimers and O-- and O--glucoside derivatives against a panel of glycosidase enzymes 
revealed that casuarine and 1-epi-australine-2-O--glucoside were the most potent compounds.9 
These alkaloids showed low M activities against several -glucosidases. For example, 
casuarine had an IC50 value of 0.7 M against rat intestinal maltase and of 0.7 M against 
amyloglucosidase from Aspergillus niger. In a separate study, uniflorine A 1 was shown to have 
moderate inhibitory activity against the -glucosidases, rat intestinal maltase and sucrase, with 
IC50 values of 12 and 3.1 M, respectively.1 The results of our glycosidase inhibitor testing for 
synthetic uniflorine A 113 are shown in Table 1. At 143 g/mL uniflorine A 1 showed 94-97% 
inhibition against the -D-glucosidases of Saccharomyces cerevisiae and Bacillus 
stearothermophilus and against amyloglucosidase of Aspergillus niger. The IC50 values were 
only determined for the two aforementioned -D-glucosidases and were found to be modest at 34 
and 28 M, respectively. 
Table 1 The glycosidase inhibition of uniflorine A 1 (Mean % Inhibition at 143 g/mL). 
 
Enzyme Source pH % Inhibitions 
-D-glucosidase Saccharomyces cerevisiae 6.8 
94 
IC50 34 M 
-D-glucosidase Bacillus 6.8 97 
11 
 
stearothermophilus IC50 28 M 
-D-glucosidase Rice 4 ND 
-D-glucosidase Almond (Prunus sp.) 5 5 
-D-galactosidase 
Green coffee bean 
(Coffea sp.) 
6.5 5 
-D-galactosidase Bovine liver 7.3 0 
-L-fucosidase Bovine kidney 5.5 ND 
-D-mannosidase 
Jack bean (Canavalia 
ensiformis) 
4.5 5 
-D-mannosidase Cellullomonas fimi 6.5 2 
naringinase Penicillium decumbens 4 ND 
N-acetyl--D-
glucosaminidase 
Bovine kidney 4.25 13 
N-acetyl--D-
glucosaminidase 
Jack bean 5 5 
N-acetyl--D-
hexosaminidase 
Aspergillus oryzae 5 ND 
amyloglucosidase Aspergillus niger 4.5 97 
-glucuronidase Bovine liver 5 0 
ND = No determined 
 Compounds 12, 13, 15, 18 and 23 along with the pyrrolizidine 2413 and the indolizidines 
25,20 262 and 272 were screened against 10 different glycosidases at 143 g/mL. None showed 
strong inhibition with only compounds 13, 18, 23, 25 and 27 showing approximately 40-50% 
inhibition against the -D-glucosidase from Bacillus stearothermophilus at this relatively high 
concentration (Table 2). 1,6-Diepi-castanospermine showed similar activity against almond -D- 




Table 2 The glycosidase inhibition of synthesized compounds (Mean % Inhibition at 143 g/mL). 
 





































































14 43 24 0 25 -10 0 13 17 0 
252 
 
0 42 16 0 21 0 -11 19 0 -7 
262 
 












20 44 13 -7 7 -25 0 0 0 0 






The total synthesis of naturally occurring 3-epi-casuarine 8 was achieved in 13 steps and in 
0.4% overall yield from L-xylose. The low overall yield was due to a poor yielding epoxide 
ring-opening reaction due to a competing intramolecular epoxide ring-opening reaction 
involving the 3--hydroxymethyl substituent. We also report the synthesis of two novel 
tricyclic ether bridged analogues of 3-epi-casuarine, plus 7-deoxy-3,6-diepi-casuarine,,7-
epi-australine, 1-epi-castanospermine and 1,6-diepi-castanospermine. The glycosidase 
inhibitory activities of these compounds, along with that of uniflorine A and other 
polyhydroxylated pyrrolizidine and indolizidines that we have published before, are 
reported. Uniflorine A showed moderate activity against the -D-glucosidases from 
Saccharomyces cerevisiae and Bacillus stearothermophilus (IC50 34 and 28 M, 




4.1 General methods: All IR spectra were run as neat samples. All NMR spectra were run 
at 500 MHz (1H NMR) or 125 MHz (13C NMR) in solutions of CDCl3 unless otherwise 
noted. NMR assignments were made on the basis of COSY, DEPT, HSQC and sometimes 
HMBC experiments. In the 1H NMR assignments of some compounds the diastereotopic H-
8 (pyrrolizidine compounds) and H-5 protons (indolizidine compounds) are referred to H-
8a and H-8b and H-5a and H-5b, respectively where the most downfield proton is labelled 
as ‘a’. Petrol refers to the hydrocarbon fraction of bp 40-60 C. FCC is an abbreviation for 









acetoxy-3-methyl-7,8-epoxyindolizidine (10), and 1,2-bis(benzyloxy)-7-acetoxy-3-
methyl-6,8-epoxy-indolizidine (11). 
To a solution of the epoxide 6 (100.0 mg, 0.208 mmol) in anhydrous CH2Cl2 (5 mL) was 
added NaHSO4 (125 mg, 1.04 mmol). The reaction mixture was stirred and heated at reflux 
for 7 d under an atmosphere of N2. The reaction was quenched by the addition of water (5 
mL) and stirred for 1 h. The solvent was removed under reduced pressure and the residue 
was extracted with EtOAc (3 x 10 mL). TLC analysis showed 4 major products. The crude 
mixture was purified by FCC (100% EtOAc to 8.0:1.5:0.5 EtOAc/MeOH/NH3). The 
fractions were not pure and they were combined, evaporated and then acetylated. To a 
solution of the crude product in pyridine (2.0 mL) was added acetic anhydride (0.184 mL, 
1.95 mmol) and a crystal of 4-dimethylaminopyridine. The mixture was stirred at rt for 24 
h. The reaction was quenched by the addition of sat. NaHCO3 solution, followed by 
removal of the solvent under reduced pressure. The residue was extracted with CH2Cl2 (3 x 
10 mL). The combined CH2Cl2 extracts were washed with water (10 mL), dried (Na2CO3), 
filtered and then evaporated. The residue was purified by FCC (90:10 EtOAc/petrol to 
8.5:1:0.5 EtOAc/MeOH/NH3) to give 8 as a pale yellow oil (7.0 mg, 7%), 10 as a 
colourless oil (6.7 mg, 8%), 9 as a pale yellow oil (8.0 mg, 9%) and 11 as a pale yellow oil 
(14.0 mg, 17%).  
8: Rf 0.47 (50:50 EtOAc/petrol). [] 22D +22.3 (c 1.4, CHCl3). MS (ESI +ve) m/z 512 (M+H
+, 
100%). HRMS (ESI +ve) calculated for C28H34NO8 (M
 +H+) 512.2284, found 512.2277. IR 
υmax (cm
-1): 2919, 1738, 1372, 1228, 1042. 1H NMR  7.36─7.26 (m, 10H, Ar), 5.32 (app. 
dt, 1H, J 8.0, 6.7 Hz, H-6), 5.22 (app. t, 1H, J 6.7 Hz, H-7), 4.61 (d, 1H, J 12.3 Hz, 
CHHPh), 4.55 (d, 1H, J 11.5 Hz, CHHPh), 4.48 (d, 1H, J 11.5 Hz, CHHPh), 4.42 (dd, 1H, 
J 11.1, 6.7 Hz, H-8), 4.37 (d, 1H, J 12.3 Hz, CHHPh), 4.34 (dd, 1H, J 11.1, 7.8 Hz, H-8), 
4.30 (brs, 1H, H-1), 3.95 (d, 1H, J 4.0 Hz, H-2), 3.49-3.45 (m, 1H, H-3), 3.40-3.30 (m, 1H, 
H-7a), 3.31 (app. t, 1H, J 7.8 Hz, H-5), 3.13 (app. t, 1H, J 8.0 Hz, H-5), 2.11 (s, 3H, 
CH3), 2.05 (s, 3H, CH3) 2.01 (s, 3H, CH3). 
13C NMR  170.9 (CO), 170.8 (CO), 170.3 
(CO), 137.7 (C), 137.6 (C), 128.5 (CH), 128.4 (CH), 127.9 (CH), 127.8 (CH), 127.7 (CH), 
127.6 (CH), 85.7 (C-1), 85.6 (C-2), 79.0 (C-7), 76.5 (C-6), 73.8 (C-7a), 71.8 (CH2), 71.7 




9: (NMR assignments are given based on the numbering system of the parent pyrrolizine 
(compare with 8 above) and are not based on the systematic compound name give in the 
title) .Rf 0.34 (100% EtOAc). MS (ESI +ve) m/z 410 (M+H
+, 100%). 1H NMR  7.41─7.23 
(m, 10H, Ar), 4.58 (d, 1H, J 12.0 Hz, CHHPh), 4.54 (d, 1H, J 11.5 Hz, CHHPh), 4.53 (d, 
1H, J 11.5 Hz, CHHPh), 4.43 (dd, 1H, J 11.3, 6.5 Hz, H-8), 4.37 (dd, 1H, J 11.3, 4.5 Hz, 
H-8), 4.36 (d, 1H, J 11.5 Hz, CHHPh), 4.03 (d, 1H, J 4.0 Hz, H-2), 3.81 (d, 1H, J 4.0 Hz, 
H-1), 3.71 (d, 2H, J 5.0 Hz, H-7a and H-6 or H-7), 3.63 (d, 1H, J 3.0 Hz, H-6 or H-7), 3.57 
(app. dd, 1H, J 11.0, 7.0 Hz, H-3), 3.25 (d, 1H, J 11.3 Hz, H-5), 3.15 (d, 1H, J 11.3 Hz, H-
5), 2.03 (s, 3H, CH3). 
13C NMR  170.9 (CO), 137.6 (C), 137.4 (C), 128.6 (CH), 128.5 
(CH), 128.1 (CH), 127.9 (CH), 127.6 (CH), 127.5 (CH), 87.4 (C-2), 84.8 (C-1), 72.2 (C-
7a), 71.8 (CH2), 71.7 (CH2), 62.4 (C-3), 60.3 (C-8), 57.4 (C-6 or C-7), 57.2 (C-6 or C-7), 
48.1 (C-5), 20.9 (CH3). 
10: Rf 0.50 (100% EtOAc). [] 25D ─14.9 (c 0.7, CHCl3). MS (ESI +ve) m/z 410 (M+H
+, 
100%). HRMS (ESI +ve) calculated for C24H28NO5 (M+H
+) 410.1967, found 410.1984. IR 
υmax (cm
-1): 2929, 2868, 1737, 1237, 1102, 1046. 1H NMR  7.38─7.26 (m, 10H, Ar), 5.24 
(dd, 1H, J 6.4, 2.8 Hz, H-6), 4.62 (d, 1H, J 12.0 Hz, CHHPh), 4.59 (d, 2H, J 12.0 Hz, 
2xCHHPh), 4.55 (d, 1H, J 12.0 Hz, CHHPh), 4.37 (d, 1H, J 4.0 Hz, H-1), 4.30 (dd, 1H, J 
5.5, 4.0 Hz, H-2), 3.95 (d, 1H, J 2.0 Hz, H-7), 3.73 (d, 1H, J 12.0 Hz, H-8), 3.65 (dd, 1H, J 
14.4, 6.4 Hz, H-5), 3.59 (dd, 1H, J 12.0, 1.8 Hz, H-8), 3.10 (d, 1H, J 2.0 Hz, H-7a), 3.07 
(dd, 1H, J 5.0, 1.8 Hz, H-3), 2.85 (dd, 1H, J 14.4, 2.8 Hz, H-5), 2.03 (s, 3H, CH3). 
13C 
NMR  170.0 (CO), 138.0 (C), 137.8 (C), 128.4 (CH), 128.3 (CH), 127.9 (CH), 127.87 
(CH), 127.8 (CH), 127.7 (CH), 85.5 (C-2), 81.9 (C-1), 78.7 (C-7), 77.1 (C-6), 72.2 (CH2), 
71.8 (CH2), 68.6 (C-7a), 62.3 (C-3), 59.8 (C-8), 56.1 (C-5), 20.9 (CH3). 
11:Rf 0.32 (100% EtOAc). MS (ESI +ve) m/z 410 (M+H
+, 100%). [] 25D ─16.7 (c 1.6, 
CHCl3). HRMS (ESI +ve) calculated for C24H28NO5 (M+H
+) 410.1967, found 410.1974. IR 
υmax (cm
-1): 2929, 2873, 1735, 1378, 1237, 1120. 1H NMR  7.41─7.26 (m, 10H, Ar), 4.97 
(brs, 1H, H-7), 4.75 (d, 1H, J 12.0 Hz, CHHPh), 4.66 (d, 1H, J 12.5 Hz, CHHPh), 4.61 (d, 
1H, J 12.0 Hz, CHHPh), 4.48 (d, 1H, J 12.0 Hz, CHHPh), 4.24─4.23 (m, 2H, H-1 and H-
2), 4.17 (s, 1H, H-6), 3.71 (d, 1H, J 10.5 Hz, H-8), 3.56─3.53 (m, 2H, H-3 and H-8), 3.47 
(d, 1H, J 13.0 Hz, H-5), 3.25 (brs, 1H, H-7a), 2.72 (dd, 1H, J 13.0, 1.0 Hz, H-5), 2.05 (s, 
3H, CH3). 




(CH), 127.8 (CH), 127.7 (CH), 127.6 (CH), 86.0 (C-1), 84.7 (C-2), 81.8 (C-7), 75.3 (C-6), 





To a solution of 8 (14 mg, 0.027 mmol) in MeOH (1 mL) was added PdCl2 (9.7 mg, 0.055 
mmol). The mixture was stirred at rt under an atmosphere of H2 (balloon) for 4 d. The 
mixture was filtered through a celite pad and the solids were washed with MeOH. The 
combined filtrates were evaporated in vacuo and the residue was dissolved in water (1 mL) 
and applied to a column of Amberlyst A-26 (OH─) resin (3 cm). Elution with water 
followed by evaporation in vacuo gave 3-epi-casuarine 7 as a white solid (4.3 mg, 77%). 
[] 25D +2.0 (c 0.04, H2O), lit.
10 [] 23D +5.7 (c 0.5, H2O). MS (ESI +ve) m/z 206 (M+H
+, 
100%). HRMS (ESI +ve) calculated for C8H16NO5 (M+H
 +) 206.1028, found 206.1024. IR 
υmax (cm
-1): 3300, 2924, 2901, 1361, 1027. 1H NMR (D2O)  4.28 (brs, 1H, H-1), 4.19 (dd, 
1H, J2,3 = 3.5, J1,2 = 1.5 Hz, H-2), 4.11 (dt, 1H, J5,6 = 7.8, J5,6 = J6,7 = 8.0 Hz, H-6), 4.05 (t, 
1H, J6,7 = J7,7a = 8.0 Hz, H-7), 4.00 (dd, 1H, J8,8 = 11.7, J3,8a = 6.6 Hz, H-8a), 3.94 (dd, 1H, 
J8,8 = 11.7, J3,8b = 7.0 Hz, H-8b), 3.27 (ddd, 1H, J3,8a = 6.6, J3,8b = 7.0, J2,3 = 3.5 Hz, H-3), 
3.10 (d, 3H, J7,7a = 8.0 Hz, 2 x H-5 and H-7a). 
13C NMR (D2O)  80.4 (C-1), 79.7 (C-2), 
79.2 (C-7), 75.9 (C-6), 75.5 (C-7a), 64.9 (C-3), 57.4 (C-8), 51.6 (C-5). 
 
1,2-Bis(benzyloxy)-6-hydroxyl-3-methyl-7,8-epoxyindolizidine (10a) and 3-methyl 
1,2,6-trihydroxyl-7,8-epoxyindolizidine (12). 
 
To a solution of 10 (13.4 mg, 0.033 mmol) in MeOH (1 mL) was 
added Amberlyst A-26 (OH─) resin (40 mg). The reaction was 
stirred for 12 h at rt then filtered through a celite pad and the solids 
were washed with MeOH (10 mL). The filtrate was evaporated in 
vacuo to give 10a as a pale yellow oil that was used to next step without purification. MS 
(ESI +ve) m/z 368 (M+H+, 100%). HRMS (ESI +ve) calculated for C22H26NO4 (M
 +H+) 
368.1844, found 368.1862. IR υmax (cm
-1): 3385, 2925, 2863, 1454, 1362, 1099, 1070. 1H 
NMR 7.37─7.26 (m, 10H, Ar), 4.63 (d, 1H, J 12.0 Hz, CHHPh), 4.59 (d, 1H, J 11.5 Hz, 
CHHPh), 4.57 (d, 1H, J 11.5 Hz, CHHPh), 4.54 (d, 1H, J 12.0 Hz, CHHPh), 4.49 (dd, 1H, 




1H, J 2.0 Hz, H-7), 3.68 (d, 1H, J 12.0 Hz, H-8), 3.53 (dd, 1H, J 13.0, 6.2 Hz, H-5), 3.50 
(dd, 1H, J 12.0, 2.5 Hz, H-8), 3.24 (brs, 1H, H-7a), 3.02 (brd, 1H, J 3.0 Hz, H-3), 2.86 (dd, 
1H, J 13.0, 2.5 Hz, H-5). 13C NMR  138.0 (C), 137.9 (C), 128.3 (CH), 127.9 (CH), 127.8 
(CH), 127.7 (CH), 127.6 (CH), 85.5 (C-2), 82.0 (C-1), 81.5 (C-7), 75.1 (C-6), 72.2 (CH2), 
71.7 (CH2), 67.8 (C-7a), 62.3 (C-3), 59.8 (C-8), 57.9 (C-5). 
To a solution of crude 10a in MeOH (1 mL) was added PdCl2 (8.71 mg, 0.05 mmol). The 
mixture was stirred at rt under an atmosphere of H2 (balloon) for 24 h The mixture was 
filtered through a celite pad and the solids were washed with MeOH. The combined 
filtrates were evaporated in vacuo and the residue was dissolved in water (1 mL) and 
applied to a column of Amberlyst A-26 (OH─) resin (3 cm). Elution with water followed by 
evaporation in vacuo gave 12 as a pale yellow solid (5.0 mg, 82%). [] 23D  +8.6 (c 0.5, 
H2O). MS (ESI +ve) m/z 188 (M+H
+, 100%). HRMS (ESI +ve) calculated for C8H14NO4 
(M+H+) 188.0923, found 188.0928. IR υmax (cm
-1): 3395, 2965, 2934, 1316, 1033. 1H NMR 
(D2O)  4.41 (dd, 1H, J5,6 = 6.0, J5,6 = 2.3 Hz, H-6), 4.27 (brd, 1H, J1,2 = 4.3 Hz, H-1), 4.20 
(brdd, 1H, J2,3 = 5.3, J1,2 = 4.3 Hz, H-2), 3.87 (brs, 1H, H-7), 3.62─3.54 (m, 3H, 2 x H-8 
and H-5), 2.96 (brs, 1H, H-7a), 2.94 (brd, 1H, J2,3 = 5.3 Hz, H-3), 2.63 (dd, 1H, J5,5 = 
14.5, J5,6 = 2.3 Hz, H-5).13C NMR (D2O)  81.4 (C-7), 79.9 (C-2), 75.8 (C-1), 74.4 (C-6), 
70.6 (C-7a), 63.7 (C-3), 59.5 (C-8), 56.8 (C-5). 
 
1,2-Bis(benzyloxy)-7-hydroxyl-3-methyl-6,8-epoxyindolizidine (11a) and 3-methyl-
1,2,7-trihydroxyl-6,8-epoxyindolizidine (13). 
 
To a solution of 11 (14.0 mg, 0.034 mmol) in MeOH (1 mL) was added 
Amberlyst A-26 (OH─) resin (42 mg). The reaction was stirred for 16 h 
at rt, the mixture was filtered through a celite pad and the solids were 
washed with MeOH (10 mL). The filtrate was evaporated in vacuo to 
give 11a as a pale yellow oil that was used to next step without purification. MS (ESI +ve) 
m/z 368 (M+H+, 100%). HRMS (ESI +ve) calculated for C22H26NO4 (M
 +H+) 368.1844, 
found 368.1862. IR υmax (cm
-1): 3365, 2919, 2863, 1440, 1115, 1014. 1H NMR 7.42─7.26 
(m, 10H, Ar), 4.73 (d, 1H, J 12.0 Hz, CHHPh), 4.61 (d, 1H, J 12.0 Hz, CHHPh), 4.56 (d, 
1H, J 12.0 Hz, CHHPh), 4.49 (d, 1H, J 12.0 Hz, CHHPh), 4.24 (app. t, 1H, J 6.3 Hz, H-2), 




10.5 Hz, H-8), 3.54─3.51 (m, 2H, H-3 and H-8), 3.40 (d, 1H, J 13.0 Hz, H-5), 3.07 (d, 1H, 
J 3.8 Hz, H-7a), 2.77 (d, 1H, J 13.0 Hz, H-5). 13C NMR  138.3 (C), 138.0 (C), 128.5 (CH), 
128.4 (CH), 128.2 (CH), 127.9 (CH), 127.7 (CH), 127.6 (CH), 85.6 (C-1), 84.7 (C-2), 81.0 
(C-7), 77.3 (C-6), 76.0 (C-7a), 72.6 (CH2), 72.5 (CH2), 62.7 (C-3), 55.4 (C-8), 48.6 (C-5). 
To a solution of crude 11a in MeOH (1 mL) was added PdCl2 (9.1 mg, 0.051 mmol). The 
mixture was stirred at rt under an atmosphere of H2 (balloon) for 24 h. The mixture was 
filtered through a celite pad and the solids were washed with MeOH. The filtrate was 
evaporated in vacuo and the residue was dissolved in water (1 mL) and applied to a column 
of Amberlyst A-26 (OH─) resin (3 cm). Elution with water followed by evaporation in 
vacuo gave 13 as a yellow solid (3.4 mg, 53%). [] 23D  +7.6 (c 0.34, H2O). MS (ESI +ve) 
m/z 188 (M+H+, 100%). HRMS (ESI +ve) calculated for C8H14NO4 (M
 +) 188.0923, found 
188.0928. IR υmax (cm
-1): 3380, 2919, 1114, 1054, 1033. 1H NMR (D2O)  4.25 (t, 1H, J1,2 
= J2,3 = 7.3 Hz, H-2), 4.22 (s, 2H, H-6 and H-7), 4.16 (dd, 1H, J1,2 = 7.3, J1,7a = 4.3 Hz, H-
1), 3.76 (dd, 1H, J8a,8b = 12.5, J3,8a = 7.3 Hz, H-8a), 3.69 (d, 1H, J8a,8b = 12.5 Hz, H-8b), 
3.63 (d, 1H, J5,5 = 14.0 Hz, H-5), 3.54 (t, 1H, J2,3 = J3,8a = 7.3 Hz, H-3), 3.08 (d, 1H, J1,7a = 
4.3 Hz, H-7a), 2.80 (d, 1H, J5,5 = 14.0 Hz, H-5). 
13C NMR (D2O)  80.2 (C-6), 79.5 (C-1), 
77.9 (C-7), 77.7 (C-2), 76.5 (C-7a), 64.3 (C-3), 54.9 (C-8), 47.7 (C-5). 
 
(1R,2R,3S,6S,7aR)-3-(Hydroxymethyl)hexahydro-1H-pyrrolizine-1,2,6-triol (15). 
To a solution of 14 (12 mg, 0.025 mmol) in MeOH (1 mL) was added PdCl2 (6.6 mg, 0.037 
mmol). The mixture was stirred at rt under an atmosphere of H2 (balloon) for 3 h, followed 
by the dropwise addition of conc. HCl (5 drops). The mixture was stirred at rt for 21 h. The 
mixture was filtered through a celite pad and the solids were washed with MeOH. The 
combined filtrates were evaporated in vacuo and the residue was dissolved in water (1 mL) 
and applied to a column of Amberlyst A-26 (OH─) resin (3 cm). Elution with water 
followed by evaporation in vacuo gave product as a white solid (4.0 mg). However, the 1H 
NMR spectrum of this compound showed an impure product and therefore this compound 
was acetylated. To a solution of the above product in pyridine (0.5 mL) was added acetic 
anhydride (20 μL, 0.254 mmol) and a crystal of 4-dimethylaminopyridine. The mixture was 
stirred at rt for 24 h. The reaction was quenched by the addition of sat. NaHCO3 solution, 
followed by removal of the solvent under reduced pressure and the residue was extracted 




(Na2CO3) and evaporated. The crude product was purified by FCC (70:30 EtOAc/petrol to 
8.5:1:0.5 EtOAc/MeOH/NH3) to give the tetraacetate derivative of 15 as a pale yellow oil 
(3.6 mg). Rf 0.49 (90:10 EtOAc/MeOH). MS (ESI +ve) m/z 358 (M+H
+, 100%). [] 23D
─10.6 (c 0.3, CHCl3). IR υmax (cm
-1): 2924, 2825, 1736, 1372, 1221, 1039. 1H NMR  5.40 
(app. t, 1H, J 4.5 Hz, H-6), 5.35 (dd, 1H, J 5.0, 1.5 Hz, H-2), 4.83 (brd, 1H, J 1.5 Hz, H-1), 
4.38 (dd, 1H, J 12.0, 6.5 Hz, H-8), 4.23 (dd, 1H, J 12.0, 7.0 Hz, H-8), 3.75 (app. dt, 1H, J 
6.3, 5.0 Hz, H-3), 3.59-3.55 (ddd, 1H, J 7.5, 3.0, 3.0 Hz, H-7a), 3.27 (dd, 1H, J 10.5, 4.0 
Hz, H-5), 2.99 (d, 1H, J 10.5 Hz, H-5), 2.35 (dd, 1H, J 14.3, 7.8 Hz, H-7), 2.13─2.05 (m, 
13H, 4 x CH3 and H-7).
13C NMR  170.8 (CO), 170.6 (CO), 170.1 (CO), 169.3 (CO), 82.7 
(C-1), 79.8 (C-2), 75.6 (C-6), 69.3 (C-7a), 61.0 (C-3), 59.6 (C-8), 53.6 (C-5), 36.3 (C-7), 
21.3 (CH3), 20.9 (2 x CH3), 20.8 (CH3). 
To a solution of the above tetraacetate (3.6 mg, 0.010 mmol) in MeOH (1 mL) was added 
Amberlyst A-26 (OH─) resin (15 mg). The reaction was stirred for 3 h at rt, the mixture was 
then filtered through a celite pad and the solids were washed with MeOH (10 mL). The 
combined filtrates were evaporated in vacuo to give 7-deoxy-3,6-diepi-casuarine 15 as a 
pale yellow solid (2.3 mg, 50%). [] 23D  +28.6 (c 0.23, MeOH). MS (ESI +ve) m/z 190 
(M+H+, 100%). HRMS (ESI +ve) calculated for C8H16NO4 (M+H
+) 190.1079, found 
190.1074. IR υmax (cm
-1): 3400, 2923, 2852, 1460, 1053, 1038. 1H NMR (D2O)  4.57 (brs, 
1H, H-6), 4.22 (brs, 1H, H-2), 4.09 (brs, 1H, H-1), 4.00 (dd, 1H, J8a,8a = 11.4 Hz, J3,8a = 6.7 
Hz, H-8a), 3.92 (dd, 1H, J8a,8b = 11.4, J3,8b = 6.7 Hz, H-8b), 3.59 (t, 1H, J1,7a = J7,7a = 7.8 
Hz, H-7a), 3.41 (brs, 1H, H-3), 3.31 (dd, 1H, J5,5 = 10.5, J5,6 = 2.5, H-5), 2.92 (d, 1H, J5,5 = 
10.5 Hz, H-5), 2.22─2.17 (m, 1H, H-7), 2.04─2.00 (m, 1H, H-7). 13C NMR (D2O)  81.1 




To a solution of the epoxide 1613 (20.0 mg, 0.042 mmol) in anhydrous THF (1 mL) was 
added dropwise a 1 M solution of lithium aluminium hydride in THF (62.4 μL, 0.062 
mmol). The reaction was stirring for 20 h at rt and then evaporated to leave a residue which 
was chromatographed on silica gel by FCC (20:80 EtOAc/petrol to 100% EtOAc) to give 




CHCl3). MS (ESI +ve) m/z 484 (M+H
+, 100%). HRMS (ESI +ve) calculated for 
C28H42NO4Si (M+H
+) 484.2883, found 484.2871.IR υmax (cm
-1): 3390, 3030, 2922, 2850, 
1248, 1092. 1H NMR  7.40─7.25 (m, 10H, Ar), 4.96 (d, 1H, J 12.0 Hz, CHHPh), 4.73 (d, 
1H, J 12.0 Hz, CHHPh), 4.70 (d, 1H, J 12.0 Hz, CHHPh), 4.60 (d, 1H, J 12.0 Hz, CHHPh), 
4.15 (brs, 1H, H-6), 4.01 (app. dt, 1H, J 9.4, 4.8 Hz, H-1), 3.80 (app. t, 1H, J 9.2 Hz, H-8), 
3.35 (dd, 1H, J 9.2, 3.0 Hz, H-7), 2.94─2.90 (m, 2H, H-5 and H-3), 2.40 (app. dt, 1H, J 8.8, 
8.0 Hz, H-3), 2.22─2.14 (m, 2H, H-5 and H-2), 1.95 (dd, 1H, J 9.4, 5.8 Hz, H-8a), 
1.59─1.53 (m, 1H, H-2), 0.90 (s, 9H, t-Bu), 0.08 (s, 3H, CH3), 0.04 (s, 3H, CH3). 
13C NMR 
 138.6 (C), 138.5 (C), 128.5 (CH), 128.4 (CH), 128.3 (CH), 127.8 (CH), 127.5 (CH), 
127.4 (CH), 85.2 (C-7), 78.5 (C-8), 75.2 (C-1), 74.7 (CH2), 73.4 (C-8a), 71.7 (CH2), 68.2 





To a solution of 17 (37.9 mg, 0.079 mmol) in MeOH (2 mL) was added PdCl2 (20.9 mg, 
0.112 mmol). The mixture was stirred at rt under an atmosphere of H2 (balloon) for 12 h, 
followed by the dropwise addition of conc. HCl (10 drops), The mixture was stirred at rt for 
3 d. The mixture was filtered through a celite pad and the solids were washed with MeOH. 
The filtrate was evaporated in vacuo and the residue was dissolved in water (1.5 mL) and 
applied to a column of Amberlyst A-26 (OH─) resin (3 cm). Elution with water followed by 
evaporation in vacuo gave 1,6 diepi-castanospermine 18 in 95% purity, as a yellow viscous 
oil (14 mg). [] 25D  ─74.2 (c 1.5, MeOH), lit.
16 [] 24D ─72.0 (c 0.7, MeOH). MS (ESI +ve) 
m/z 190 (M+H+, 100%). HRMS (ESI +ve) calculated for C8H16NO4 (M+H
+) 190.1079, 
found 190.1072. IR υmax (cm
-1): 3365, 3308, 2914, 2888, 1444, 1202, 1060. 1H NMR (D2O) 
 4.29─4.25 (m, 1H, H-1), 4.03 (brs, 1H, H-6), 3.68 (t, 1H, J7,8 = J8,8a = 9.4 Hz, H-8), 3.53 
(dd, 1H,  J7,8 = 9.4, J6,7 = 3.5 Hz, H-7), 3.05 (dd, 1H, J5a,5b = 12.7, J5a,6 = 2.5 Hz, H-5a), 
2.92 (app. t, 1H, J = 8.5 Hz, H-3), 2.48 (dt, 1H, J2,3 = J3,3 = 9.3, J2,3 = 9.0 Hz, H-3), 2.42 (d, 
1H, J5a,5b = 12.7 Hz, H-5b), 2.34─2.25 (m, 1H, H-2), 1.99 (dd, 1H, J8,8a = 9.4, J1,8a = 6.5 
Hz, H-8a), 1.67─1.62 (m, 1H, H-2). 13C NMR (D2O)  75.8 (C-7), 74.6 (C-1), 74.0 (C-8a), 






australine (21)).  
To a solution of a 92:8 mixture of 19 and 20 (37.1 mg, 0.077 mmol) MeOH (2 mL) was 
added PdCl2 (20.4 mg, 0.115 mmol). The mixture was stirred at rt under an atmosphere of 
H2 (balloon) for 3 h, followed by the dropwise addition of conc. HCl (8 drops). The mixture 
was stirred at rt for 17 h and was then filtered through a celite pad and the solids were 
washed with MeOH. The combined filtrates were evaporated in vacuo and the residue was 
dissolved in water (1.5 mL) and applied to a column of Amberlyst A-26 (OH─) resin (3 
cm). Elution with water followed by evaporation in vacuo gave 7-epi-australine 21 (dr 
92:8) as a pale yellow solid (13.0 mg, 90%). [] 23D  ─13.2 (c 1.2, H2O), lit.
17 [] 25D ─13.04 
(c 0.55, H2O, pH 8.37) MS (ESI +ve) m/z 190 (M+H
+, 100%). HRMS (EI +ve) calculated 
for C8H15NO4 (M
 +) 189.1001, found 189.0999. IR υmax (cm
-1): 3358, 2980, 1340, 1126, 
1027. 1H NMR (D2O)  4.34 (brs, 1H, H-7), 3.77 (dd, 1H, J8a,8b = 12.0, J3,8a= 4.5 Hz, H-
8a), 3.76 (t, 1H, J1,2 = J2,3 = 8.5 Hz, H-2), 3.71 (t, 1H, J1,2 = J1,7a = 8.0 Hz, H-1), 3.64 (dd, 
1H, J8a,8 = 11.8, J3,8b= 5.8 Hz, H-8b), 3.08 (dd, 1H, J5,5 = J5,6 10.8, J5,6 = 6.0 Hz, H-5), 3.01 
(brd, 1H, J1,7a= 8.0 Hz, H-7a), 2.89─2.84 (m, 1H, H-5), 2.69─2.64 (m, 1H, H-3), 
2.11─2.04 (m, 1H, H-6), 1.80─1.74 (m, 1H, H-6). 13C NMR (D2O)  78.6 (C-1), 77.0 (C-
2), 75.8 (C-7), 74.5 (C-7a), 69.0 (C-3), 63.4 (C-8), 52.4 (C-5), 32.3 (C-6). 
 
(1R,6S,7R,8R,8aR)-Octahydroindolizine-1,6,7,8-tetraol (1-epi-castanospermine (23)). 
To a solution of 22 (9.0 mg, 0.019 mmol) MeOH (1 mL) was added PdCl2 (6.6 mg, 0.037 
mmol). The mixture was stirred at rt under an atmosphere of H2 (balloon) for 3 h, followed 
by the dropwise addition conc. HCl (4 drops). The mixture was stirred at rt for 21 h and 
was then filtered through a celite pad and the solids were washed with MeOH. The filtrate 
was evaporated in vacuo and the residue was dissolved in water (1 mL) and applied to a 
column of Amberlyst A-26 (OH─) resin (3 cm). Elution with water followed by evaporation 
in vacuo gave 1-epi-castanospermine 23 as a colourless solid (3.3 mg, 94%). [] 22D  +3.3 (c 
0.3, MeOH), lit.18 [] 26D +3.8 (c 0.5, MeOH). MS (ESI +ve) m/z 190 (M+H
+, 100%). HRMS 
(ESI +ve) calculated for C8H16NO4 (M+H
+) 190.1079, found 190.1088. IR υmax (cm
-1): 
3330, 2924, 2822, 1444, 1312, 1086. 1H NMR (D2O)  4.26─4.22 (m, 1H, H-1), 3.61 (ddd, 




3.33 (app. t, 1H, J6,7 = J7,8 = 9.3 Hz, H-7), 3.16 (dd, 1H, J5a,5b= 10.8, J5a,6 = 5.7 Hz, H-5a), 
2.95 (ddd, 1H, J3,3 = 9.4, J2,3 = 8.0, J2,3 = 1.5 Hz, H-3), 2.57 (dt, 1H, J3,3 = 9.4, J2,3 = 8.5 Hz, 
H-3), 2.34-2.28 (m, 1H, H-2), 2.24 (t, 1H, J5a,5b = J5b,6 = 10.8 Hz, H-5b), 2.12 (dd, 1H, J8,8a 
= 9.3, J1,8a = 6.5 Hz, H-8a), 1.70 (app. t, 1H, J = 11.5 Hz, H-2). 
13C NMR (D2O)  79.3 (C-
7), 74.3 (C-1), 74.0 (C-8), 73.4 (C-8a), 70.5 (C-6), 55.5 (C-5), 51.4 (C-3), 33.0 (C-2). 
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